Zhaohui Ao

2.6k citations
28 papers · 1.6k indexed · h-index 18
Topics
Cardiovascular, Neuropeptides, and Oxidative Stress Research (9 papers)Apelin-related biomedical research (8 papers)Cardiovascular Disease and Adiposity (5 papers)

In The Last Decade

Zhaohui Ao

28 papers receiving 1.5k citations

Peers

Zhaohui Ao
Comparison fields: 5 of 102
  • Molecular Biology 608
  • Surgery 427
  • Immunology 408
  • Pharmacology 335
  • Cancer Research 324
Replace Xiaoming Wen with:
Xiaoming Wen United States
Adrián Recinos United States
Julio Madrigal‐Matute Spain
Zheng‐Gen Jin United States
Hiromichi Hemmi Japan
Ning Xu Sweden
Jan Fleckner Denmark
MyTrang Nguyen United States
Tomonari Koike Japan
Peter S. Gargalovic United States
Zhaohui Ao relative to Xiaoming Wen United States Xiaoming Wen's profile →
Citations per field
00.5×1.5×
Xiaoming Wen · 1×
Citations per year

Countries citing papers authored by Zhaohui Ao

Since Specialization
Citations

This map shows the geographic impact of Zhaohui Ao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaohui Ao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaohui Ao more than expected).

Fields of papers citing papers by Zhaohui Ao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaohui Ao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaohui Ao. The network helps show where Zhaohui Ao may publish in the future.

Co-authorship network of co-authors of Zhaohui Ao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaohui Ao. A scholar is included among the top collaborators of Zhaohui Ao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaohui Ao. Zhaohui Ao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 64
2 11
3 35
4 89
5 19
6 7
7 23
8 15
9 32
10 17
11 92
12 5
13 49
14 15
15 109
16 5
17 3
18 68
19 42
20 8

About Zhaohui Ao

Zhaohui Ao is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Immunology, having authored 28 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cardiovascular, Neuropeptides, and Oxidative Stress Research (9 papers), Apelin-related biomedical research (8 papers) and Cardiovascular Disease and Adiposity (5 papers). The work is most often cited by research in Cancer Research (324 citations), Pharmacology (335 citations) and Immunology (408 citations). Zhaohui Ao has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Stuart F. Schlossman, Kartik Prasad, Mei X. Wu, Stephen A. Douglas, Ruilian Wu, Douglas G. Johns, Nambi Aiyar, Yoosik Yoon, Serge Jacquot and Robert N. Willette. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026